Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.
|ClinicalTrials.gov Identifier: NCT03435484|
Recruitment Status : Completed
First Posted : February 19, 2018
Last Update Posted : August 9, 2019
|Condition or disease||Intervention/treatment||Phase|
|Patient-reported Outcomes||Other: Current Instructions Other: Additional Instructions||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||27263 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Using Rapid Cycle Randomized Controlled Trials to Increase Completion Rates of the Patient-Reported Health Assessment Questionnaire During Outpatient Visits at NYU Langone Orthopedic Center|
|Actual Study Start Date :||February 7, 2018|
|Actual Primary Completion Date :||May 31, 2019|
|Actual Study Completion Date :||May 31, 2019|
Active Comparator: Usual Care
Participants in this group will receive the current version of instructions (a verbal reminder) for completing the Health Assessment Questionnaire.
Other: Current Instructions
Participants will receive a verbal reminder to complete the Health Assessment Questionnaire from the intake personnel, as part of usual care.
Active Comparator: Additional Instructions
Participants in this group will be exposed to additional instructions that remind them to complete the Health Assessment Questionnaire.
Other: Additional Instructions
Intervention includes various iterations of instructions for completing the Health Assessment Questionnaire. Participants will receive these instructions in addition to the verbal reminder from the intake personnel (usual care).
- Questionnaire Completion Rate (number of times patients complete or partially complete the questionnaire). [ Time Frame: Duration of the study, up to 6 months. ]Completion rate data is routinely collected by the medical center.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03435484
|United States, New York|
|New York University School of Medicine|
|New York, New York, United States, 10016|
|Principal Investigator:||Leora Horwitz, MD, MHS||NYU Langone Health|